SMS International Ltd, London announced today that they have commenced the manufacture of Nicotine Polacrilex Resin, USP at their plant, beginning from very basic stages. Their proprietary, state of the art, integrated manufacturing process will significantly reduce the costs of nicotine replacement therapies.
SMS offers Nicotine Polacrilex Resin USP24 (10-20 pct Nicotine) for chewing gums and lozenges and Nicotine gel (10-15 pct) for transdermal patches. More information can be found at their website:
Another significant development at SMS, is their Directly Compressible Grade (ready to compress) pre-formulated Product mix which can be directly compressed to chewing gums as well as lozenges in a typical tablet-packing line. This eliminates the need for expensive air-handling systems, since the product mix supplied would contain 2-4mg of Nicotine per 1000mg of the DC grade material.
SMS is now looking at prospective licensing opportunities all over the world and intends to select a partner in every country looking for NRT's ( Nicotine Replacement Therapies). They are in contact with bodies such as TFI (tobacco free initiative) of WHO (World Health Organization) and others to assist and guide them in this exercise to find interested parties in many countries, with a focus on Mainland China, USA, EU, Central Europe, Japan, Indonesia, Zimbabwe, Egypt to name a few.